Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10145 (
IL-8
)
23,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Interleukin-8
(
IL-8
) is a peptide which is secreted by stimulated human monocytes and which is chemotactic for human neutrophils. We synthesized three overlapping peptides spanning the amino-terminal region of the
IL-8
sequence. None of the peptides retained the chemotactic activity of the native molecule. One of the peptides,
IL-8
(3-25), inhibited the neutrophil chemotactic activity of recombinant
IL-8
(rIL-8) which had been preheated to 40 degrees C but did not reduce neutrophil chemokinesis, or the chemotactic activity of unheated rIL-8, FMLP, C5a or LTB4.
Interleukin-8
exhibited similar binding kinetics and chemotaxis for neutrophils regardless of whether it had been pretreated at 40 degrees C. In addition,
IL-8
(3-25) was also able to decrease the binding of preheated
IL-8
to neutrophils.
IL-8
(3-25), which can self-associate, binds directly to receptors on the neutrophil. The data suggest that heat-treated, but not untreated,
IL-8
causes the
IL-8
(3-25) multimers to disaggregate, allowing the monomeric peptide to directly bind to the
IL-8 receptor
and thus inhibiting
IL-8
/receptor binding.
...
PMID:A synthetic peptide which specifically inhibits heat-treated interleukin-8 binding and chemotaxis for neutrophils. 802 44
Interleukin-8
(
IL-8
) is a potent chemotactic and proinflammatory cytokine, produced in the skin by a variety of cells in response to inflammatory stimuli. Recent studies suggest that in addition to its potent actions on leukocytes,
IL-8
exerts a direct influence on several functions of human epidermal cells such as chemotaxis, Candida albicans killing activity or proliferation. The effects of
IL-8
are mediated by binding to two types of specific high-affinity receptors which contain seven transmembrane domains typical of guanine nucleotide binding protein (G protein)-coupled receptors. In the skin, a broad spectrum of cells such as neutrophils, T lymphocytes, mast cells, dermal macrophages, endothelial cells and keratinocytes possess binding sites for
IL-8
. Recently, increased expression of epidermal
IL-8
receptors has been observed in psoriasis an inflammatory and hyperproliferative skin disease. Since the effects of
IL-8
may be modulated at the receptor level, the pharmacological manipulation of the
IL-8 receptor
may prove an important target for the therapy of skin diseases with increased
IL-8
levels.
...
PMID:Role of interleukin-8 receptor in skin. 803 9
IL-8
mediates migration and activation of neutrophils. This study describes the functional and ligand binding specificity of the human intercrine peptides
IL-8
, neutrophil-activating peptide 2 (NAP-2), melanoma growth stimulatory activity (GRO), and platelet factor 4 (PF4) to rabbit neutrophils and mammalian cell lines transfected with rabbit
IL-8 receptor
cDNA (F3R). Rabbit neutrophil membranes bound 125I-labeled
IL-8
and 125I-labeled NAP-2 but did not bind 125I-labeled GRO or 125I-labeled PF4. Rabbit neutrophils mobilized intracellular Ca2+ in response to
IL-8
and NAP-2 but not to GRO or PF4. Monkey kidney cells (COS-7) and hamster lung fibroblasts (CCL-39) were transiently and stably transfected with the rabbit neutrophil
IL-8 receptor
F3R cDNA. COS-7 cells transfected with F3R cDNA bound 125I-labeled
IL-8
but did not bind other
IL-8
-related peptides such as 125I-labeled NAP-2, 125I-labeled GRO, or 125I-labeled PF4. Furthermore, bound 125I-labeled
IL-8
was only displaced by unlabeled
IL-8
but not by unlabeled NAP-2, GRO alpha, or PF4. Consistent with this observation, stably transfected CCL 39 cells expressing F3R cDNA mobilized Ca2+ only in response to
IL-8
. We conclude that F3R cDNA encodes a functional
IL-8 receptor
isotype with strict ligand binding specificity for
IL-8
, that rabbit neutrophils do not bind human GRO alpha, and it is suggested that rabbit neutrophils contain in addition to the F3R protein another
IL-8 receptor
isotype with broad ligand specificity or a distinct NAP-2 receptor.
...
PMID:Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor. 813 60
Neutrophil leukocytes, the target cells for interleukin-8 and related CXC chemokines, bear high numbers of two types of
IL-8
receptors (IL-8R1 and IL-8R2). By cDNA transfection Jurkat cell lines were generated that stably express either IL-8R1 or IL-8R2 (J-
IL8R1
and J-IL8R2). J-
IL8R1
expressed 4,000 +/- 1,000 copies of IL-8R1, and bound
IL-8
with high affinity (Kd 1-4 nM) and GRO alpha and NAP-2 with low affinity (Kd 200-500 nM). J-IL8R2 expressed 17,000 +/- 3,000 copies of IL-8R2, and bound all three chemokines with high affinity. Both transfectants showed a similar degree of chemotactic migration after stimulation with
IL-8
, GRO alpha and NAP-2. All three chemokines were equally potent as attractants of J-IL8R2, whereas
IL-8
was 300 to 1,000-fold more potent than GRO alpha or NAP-2 as attractant of J-
IL8R1
. The potencies, therefore, agree with the affinities of the ligands to IL-8R1 and IL-8R2. Our results demonstrate that both
IL-8
receptors function independently, and mediate chemotaxis in response to
IL-8
and other CXC chemokines.
...
PMID:Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2. 813 38
Although the potent neutrophil chemotaxin,
IL-8
, is a known product of endotoxin-stimulated cells in vitro, the contribution of
IL-8
to neutrophil recruitment in Gram-negative endotoxin inflammation in vivo is unknown. To determine whether neutralization of
IL-8
would decrease endotoxin-induced neutrophil influx, we generated neutralizing mAbs to rabbit rIL-8 for use in our rabbit model of endotoxin-induced pleurisy. One mAb, ARIL8.2, specifically inhibited both rabbit rIL-8-induced chemotactic activity and activation of the rabbit
IL-8 receptor
transfected in 293 cells. Anesthetized rabbits with in-dwelling pleural catheters received either neutralizing mAb (ARIL8.2; 1 mg/kg) or irrelevant isotype-matched mAb (anti-HIV gp120) i.v. 1 h before as well as intrapleurally (20 micrograms/ml) at the time of intrapleural instillation of Escherichia coli endotoxin (200 ng bilaterally). ARIL8.2 blocked 77% of endotoxin-induced neutrophil influx (21 +/- 2 (SE) x 10(6) (ARIL8.2) vs 91 +/- 15 x 10(6) (anti-gp120) (p < 0.0001)). By Western analysis, a band corresponding to rabbit
IL-8
was detected in the pleural liquid of rabbits in both groups. By ELISA, however, the concentration of free, unbound
IL-8
in the pleural liquid was significantly less in the ARIL8.2 group than in the anti-gp120 group for at least 4 h, confirming that ARIL8.2 bound the
IL-8
generated in vivo during that time. We conclude that neutralization of
IL-8
profoundly inhibits neutrophil recruitment in endotoxin-induced pleurisy indicating that
IL-8
is a major chemotactic factor in this model of acute inflammation.
...
PMID:Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. 814 95
Interleukin-8
(
IL-8
) mediates the transendothelial migration and activation of neutrophils to the site of inflammation. Two human
IL-8 receptor
isotype (A and B) and one rabbit
IL-8 receptor
isotype (A) cDNAs have been previously cloned and characterized on the basis of their pharmacological profile. Human and rabbit
IL-8 receptor
subtype A binds
IL-8
and structurally related peptide melanoma growth-stimulating activity (MGSA) and neutrophil-activating peptide-2 (NAP-2) according to the following affinity binding profile:
IL-8
>>> MGSA > NAP-2, whereas the human
IL-8 receptor
subtype B profile is
IL-8
= MGSA > NAP-2 (LaRosa, G., Thomas, K. M., Kaufmann, M., Mark, R., White, M., Taylor, L., Gray, G., Witt, D., and Navarro, J. (1992) J. Biol. Chem. 267, 25402-25406). In this study, we isolated a cDNA clone (5B1a) from a rabbit neutrophil library encoding a G-protein-coupled receptor of the interleukin-8 receptor family. The 5B1a clone encodes a 358-amino acid protein exhibiting 80% amino acid identity to the human
IL-8 receptor
B, 74% to the rabbit
IL-8 receptor
A, and 73% to the human
IL-8 receptor
A. Tissue distribution by Northern blot analysis reveals that the 5B1a mRNA is expressed preferentially in neutrophils. In contrast to previously described
IL-8
receptors, the 5B1a receptor exhibited specific 125I-
IL-8
binding with a novel affinity binding profile of
IL-8
>> NAP-2 > MGSA. The corresponding apparent Ki values for
IL-8
, NAP-2, and MGSA were 4, 120, and 320 nM, respectively.
IL-8
induced intracellular calcium mobilization and desensitization in Chinese hamster ovary cells stably transfected with 5B1a, indicating that this cDNA encodes a functional
IL-8 receptor
. Sequence analysis of the 5B1a protein with other
IL-8 receptor
subtypes within the framework of their pharmacological profile reveals putative structural motifs that may correspond to the ligand binding site of the
IL-8 receptor
.
...
PMID:Molecular characterization of a novel rabbit interleukin-8 receptor isotype. 817 42
By chemical cross-linking experiments we show that at physiologically relevant concentrations
IL-8
and NAP-2 monomers are in an equilibrium with dimers and even oligomers (KD approximately 300-800 nM). Oligomerization seems to be more prevalent for
IL-8
than for NAP-2. The form in which
IL-8
and NAP-2 bind to their specific receptors was analyzed in binding experiments with COS-1 cells expressing
IL-8 receptor
A or B in recombinant forms. Both receptors were cloned from the human myeloid leukemic cell line AML-193. Type A receptor had high affinity for
IL-8
(KD approximately 4 nM) and low affinity for NAP-2 (KD > or = 700 nM), whereas the type B receptor was of equally high affinity (KD approximately 2 nM) for both
IL-8
and NAP-2. However,
IL-8 receptor
B could bind specifically three to four times more
IL-8
than NAP-2, and NAP-2 was a weak competitor for
IL-8
binding to the same receptor. In addition,
IL-8
, but not NAP-2, could be cross-linked to dimers when bound to
IL-8 receptor
B. We suggest from these findings that
IL-8
, but not NAP-2, binds as a dimer and oligomer to
IL-8 receptor
.
...
PMID:Monomer-dimer equilibria of interleukin-8 and neutrophil-activating peptide 2. Evidence for IL-8 binding as a dimer and oligomer to IL-8 receptor B. 819 2
The
interleukin 8
(
IL-8
)-receptor family includes two specific receptors (type A and B) that both bind
IL-8
with high affinity. These receptors have been cloned, and belong to a superfamily of G-protein-linked receptors that signal in response to
IL-8
on a variety of cell types. In contrast to these receptors, which have a narrow ligand-binding profile, a promiscuous
IL-8 receptor
has been found on human erythrocytes that binds a variety of chemokines with high affinity. This protein, known as the chemokine receptor, was recently shown to bind the malarial parasite Plasmodium vivax, and may play a major role in inflammation by limiting the concentration of soluble chemokines in the circulation.
...
PMID:The interleukin-8-receptor family: from chemokines to malaria. 819 8
The class II
IL-8 receptor
(IL-8R) binds both melanoma growth stimulatory activity (MGSA) and
IL-8
with high affinity. Reverse transcriptase polymerase chain reaction demonstrates that the class II IL-8R mRNA, which has previously been detected only in cells of hematopoietic lineage, is also expressed in non-hematopoietic cell types shown to respond to MGSA or
IL-8
. To study the signaling mechanism by MGSA through the class II IL-8R in non-hematopoietic cells, this receptor was overexpressed in the 3ASubE human placental and the 293 human kidney cell lines. Membrane preparations of the class II IL-8R expressing 3ASubE transfectants exhibited a 2.3 +/- 0.2-fold increase in GTP gamma 35S binding, which was sensitive to pertussis toxin, in response to MGSA treatment (0.2 microM). This MGSA response was not observed in cells transfected with the parental expression vector. In vivo phosphorylation studies demonstrated that the class II IL-8R was basally phosphorylated in the untreated transfectants, and MGSA (5 nM) treatment markedly enhanced the phosphorylation of this receptor. The MGSA-induced receptor phosphorylation was both time and concentration dependent and could be mimicked by treatment with the calcium ionophore A23187. Phosphoamino acid analysis indicated that the MGSA-induced receptor phosphorylation was on serine residue(s), suggesting that a serine kinase is activated in response to MGSA binding to the class II IL-8R in non-hematopoietic cells.
...
PMID:Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells. 829 49
Interleukin-8
and its receptors are key mediators of immune and inflammatory responses. Heteronuclear NMR spectroscopy has been utilized to map the binding surface on interleukin-8 (IL-8) for an N-terminal fragment of the human Type-1
IL-8 receptor
. A peptide corresponding to residues 1-40 of the IL-8 type 1 receptor (
IL8
-r1) was titrated into a sample of uniformly 15N-labeled IL-8.
IL8
-r1 binds to IL-8 with a dissociation constant of 170 +/- 50 microM assuming the peptide binds with a stoichiometry of one peptide per IL-8 monomer, exchanges rapidly (> 900 s-1) between free and bound states, and selectively perturbs the chemical environment of several IL-8 residues. The binding surface on IL-8 suggested by our results is comprised of residues in strand beta 3 of the beta-sheet (Glu48 to Cys50), the turn preceding beta 3 (Ser44), the C-terminal alpha-helix (Val61) and the irregular N-terminal loop region (Thr12, Lys15, Phe17, His18, Lys20 and Phe21). The IL-8 dimer appears to present two symmetrical binding surfaces for the
IL8
-r1 peptide, suggesting two receptor peptides may bind per dimer.
...
PMID:Mapping the binding surface of interleukin-8 complexed with an N-terminal fragment of the type 1 human interleukin-8 receptor. 830 64
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>